comparemela.com

Latest Breaking News On - Philipp vitti - Page 1 : comparemela.com

FDA Approves First IND of its Kind for Allogenic Exosomal Treatment of Female Reproductive Disorder

/PRNewswire/ Vitti Labs, an AATB Accredited Tissue Bank focused on life science research, development, and manufacturing, announced today that the U.S. Food.

Miriam mckinneyPhilipp vittiTissue bankDrug administrationInvestigational new drug applicationPrimary ovarian insufficiencyOvarian insufficiencyChief science officerVitti labsPolycystic ovary syndrome

Vitti Labs Announces FDA Approval of IND Application for Phase II Clinical Trial of Combination Mesenchymal Stem Cell and Exosome Treatment of Novel Corona Virus Infection (COVID-19)

/PRNewswire/ Vitti Labs (www.vittilabs.com), an AATB Accredited Tissue Bank focused on Life Science Research, Development and Manufacturing, announced today.

United statesMiriam mckinneyPhilipp vittiTissue bankLife science researchVitti labDrug administrationInvestigational new drugUmbilical cord mesenchymal stem cellUmbilical cord mesenchymal stem cell exosomesAcute respiratory distress syndromeNovel corona virusChief scientistVitti labsUmbilical cord mesenchymal stem cellsStem cells

Vitti Labs Announces FDA Approval of IND Application for Phase II Clinical Trial of Combination Mesenchymal Stem Cell and Exosome Treatment of Novel Corona Virus Infection (COVID-19)

/PRNewswire/ Vitti Labs (www.vittilabs.com), an AATB Accredited Tissue Bank focused on Life Science Research, Development and Manufacturing, announced today.

United statesMiriam mckinneyPhilipp vittiTissue bankLife science researchVitti labDrug administrationInvestigational new drugUmbilical cord mesenchymal stem cellUmbilical cord mesenchymal stem cell exosomesAcute respiratory distress syndromeNovel corona virusChief scientistVitti labsUmbilical cord mesenchymal stem cellsStem cells

vimarsana © 2020. All Rights Reserved.